Navigation Links
BNY Mellon Appointed as Depositary by Mazor Robotics Ltd.
Date:6/10/2013

NEW YORK, June 10, 2013 /PRNewswire/ -- BNY Mellon, the global leader in investment management and investment services, has been appointed by Mazor Robotics Ltd. as depositary bank for its American depositary receipt (ADR) program. Each Mazor Robotics ADR represents two ordinary shares and trades on NASDAQ under the symbol "MZOR." Mazor Robotics' ordinary shares trade on the Tel Aviv Stock Exchange under the symbol "MZOR."

Mazor Robotics develops innovative surgical guidance systems and complementary products in the spinal surgery market that have been used in more than 35,000 implants in the U.S., Asia and Europe. Its flagship product, Renaissance™, is a state-of-the-art system that enables surgeons to conduct spinal surgeries accurately. Numerous peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability and clinical advantages of Mazor Robotics' technology.

"The momentum created by the successful market penetration of our Renaissance systems, coupled with the availability of our ADRs on NASDAQ, means U.S. investors will be able to share in our continued progress," commented Ori Hadomi, Mazor Robotics' president and CEO.

"Mazor's decision shows yet another Israeli company understanding the many benefits of DRs both for issuing companies and their investors abroad," said Christopher M. Kearns, CEO of BNY Mellon's Depositary Receipts business. "We believe their listing in the U.S. has the potential to widen Mazor's investor base dramatically."

BNY Mellon acts as depositary for more than 2,700 American and global depositary receipt programs, acting in partnership with leading companies from 68 countries. BNY Mellon is committed to helping securities issuers access the world's rapidly evolving financial markets and delivers a comprehensive suite of depositary receipt services. Learn more at www.bnymellon.com/dr

BNY Mellon is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle. Whether providing financial services for institutions, corporations or individual investors, BNY Mellon delivers informed investment management and investment services in 36 countries and more than 100 markets. As of March 31, 2013, BNY Mellon had $26.3 trillion in assets under custody and/or administration, and $1.4 trillion in assets under management. BNY Mellon can act as a single point of contact for clients looking to create trade, hold, manage, service, distribute or restructure investments. BNY Mellon is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK). Learn more at bnymellon.com, or follow us on Twitter @BNYMellon

This release is for informational purposes only. BNY Mellon provides no advice nor recommendation or endorsement with respect to any company or securities. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities. Depositary Receipts: Not FDIC, State or Federal Agency Insured; May Lose Value; No Bank, State or Federal Agency Guarantee.


'/>"/>
SOURCE BNY Mellon
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Carnegie Mellons Christopher Bettinger Develops Edible Electronics for Medical Device Industry
2. Carnegie Mellon University Biomedical Engineers Lead Collaborative Team Developing New Astro Surgery Tools for NASA Deep Space Missions
3. Parents Less Likely To Develop Colds, Carnegie Mellon Research Shows
4. Rethinking Research Ethics: Carnegie Mellon and McGill Researchers Challenge Post-marketing Trial Practices
5. Randy Hill Appointed to Vasomedical Board of Directors
6. Lynn Kramer, MD, Appointed Chief Clinical Officer of Eisai Product Creation Systems
7. Ken Mulvany Appointed Chairman of The Cure Parkinsons Trust
8. David Norton Appointed to TB Alliances Board of Directors
9. Searcy Denney Scarola Barnhart & Shipley Attorney Appointed to Plaintiffs Steering Committee for Stryker Hip Implant Litigation
10. Graham Cooper Appointed Chief Financial Officer of Receptos
11. Gregory D. Cash Appointed President and Chief Executive Officer of NeuroTherm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... Lilly and Company (NYSE: LLY ) will ... 2017 on Tuesday, October 24, 2017. Lilly will also ... investment community and media to further detail the company,s ... at 9 a.m. Eastern time. Investors, media and the ... conference call through a link that will be posted ...
(Date:10/2/2017)... 2, 2017 Halo Labs announces the European launch of ... the HORIZON at MIBio 2017 in Cambridge, U.K ... particulate matter in biopharmaceutical samples with unprecedented speed and sensitivity while ... technique Backgrounded Membrane Imaging. ... HORIZON subvisible particle analysis system ...
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
Breaking Medicine Technology:
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... that we intend to develop to enable prevention of a major side effect ... hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed ...
Breaking Medicine News(10 mins):